メディア掲載例

メディデータ･ソリューションズの製品は、いつも科学とITの世界で話題になっています。最近の実績を示す報道の例をご紹介します。

2013

The CNBC and Yahoo! Finance “Big Data Download” series features Medidata president Glen de Vries discussing how big data can help make the drug development process more efficient, cutting trial timelines and costs and ultimately creating better outcomes for patients.
全文を読む

Medidata CEO Tarek Sherif is included in Chief Executive magazine's list of “Eight State Advocate CEOs,” part of its “2013 Best and Worst States for Business” series, and is highlighted for his role promoting other tech-entrepreneurship in NYC by mentoring CEOs of start-ups and supporting local university programs that foster business innovators.
全文を読む

Speaking with TheStreet.com, Medidata CEO Tarek Sherif discusses how the Medidata Clinical Cloud is helping life science organizations bring better drugs to market, faster and with less cost and risk.
見る

Medidata president Glen de Vries is named one of the “20 Innovators Changing the Face of the Clinical Trials Industry” in the April issue of The CenterWatch Monthly for pushing the envelope of cloud-based technologies in clinical development.
全文を読む

The April issue of ACRP's The Monitor features Medidata senior product director Stephen Young as he discusses his career evolution from aerospace to the world of clinical development, and how his passion for analytics and data-driven development led him to this change.
全文を読む

A recent FierceBiotechIT article highlights the roles of Medidata Solutions and Digital Infuzion in a groundbreaking observational study by Inova Translational Medicine Institute, which will examine the correlation between a child’s genetic profile, their development and their long-term health. Together, Medidata and Digital Infuzion will deliver a web-based portal and cloud technology that will act as a repository for patient data and will enable the review of study progress and access to surveys and study information.
全文を読む

This FierceBiotechIT article offers insights from a recent webinar session, “Drugmakers go mobile,” moderated by executive editor Ryan McBride. Medidata Solutions president Glen de Vries presented—along with industry experts from Genentech, Dotmatics and Kony Solutions—on how pharma companies are embracing digital health and the use of mobile.
全文を読む

Veeva Systems' blog Veeva Voice features a post by Medidata director of product marketing Jay Smith on the challenge and potential of cloud-based electronic trial master files (eTMF) and how they can revolutionize the management of clinical trials.
全文を読む

In this eCliniqua article, Medidata product manager Igor Altman discusses the key issues for ensuring success when adopting new processes for study design optimization.
全文を読む

In a recent Software Magazine article on the evolving healthcare industry and how it opens doors for new and improved IT solutions, Medidata president Glen de Vries discusses the meaningful use of electronic health record (EHR)/electronic medical record (EMR) systems and how Medidata’s cloud-based platform helps to reduce cost, reduce risk, and enhance efficiency in all stages of the clinical trial process.
全文を読む

FierceBiotech highlights Purdue Pharma's recent multiyear deal with Medidata Solutions, broadening its already wide use of Medidata’s cloud-based solutions. The adoption will further enhance Purdue's clinical trials for pain medication.
全文を読む

In a recent PharmaVOICE article on the future of the cloud in clinical research, Medidata president Glen de Vries shares his insight on how the cloud era will go beyond convenience and speed by bringing increased productivity across the trial team.
全文を読む

In the January/February issue of Journal for Clinical Studies, Medidata’s vice president of trial planning solutions Frank Cattie discusses the three key variables of overall study cost—protocol complexity, geography and phase and indication—as well as ways for sponsors to control these variables, reduce study risk and increase performance predictability.
全文を読む

Applied Clinical Trials online in January features a Medidata Insights benchmark for source document verification (SDV) coverage. Part of a monthly series highlighting industry metrics, this edition focuses on how FDA guidance on risk-based monitoring has impacted SDV coverage across the industry.
全文を読む

2012

Forbes' Matthew Herper highlights the Forbes Healthcare Summit panel discussion on big data, led by Medidata president Glen de Vries. The feature includes video clips from the event in which Glen discusses how technology and the copious amount of data collected can help improve productivity in life sciences and health care as a whole.
全文を読む

In a recent article posted by Journal for Clinical Studies, vice president of clinical solutions Jeffrey Handen discusses the need to adopt a more responsive, adaptive and agile model for clinical trials—as well as the evolution of the tools and methodologies needed to efficiently support this model—in order to reduce the product development life-cycle in drug development.
全文を読む

In a Fast Company feature profiling managers who are navigating big job transitions, Medidata’s human resources project manager Naimisha Chanumolu discusses the challenges of going from a software engineer working alone to a project manager overseeing a team of 25.
全文を読む

In a recent PharmaVOICE article on how the optimization of certain processes in clinical development is vital for the timely and efficient approval of new treatments, director of product management Michelle Marlborough assesses the impact of unnecessary procedures in a protocol, referencing the recent Medidata-sponsored study by the Tufts Center for the Study of Drug Development.
全文を読む

In the November/December issue of PharmaVOICE, President Glen de Vries—along with other thought leaders from all sectors of the industry—offers his viewpoint on the most important business objectives for life sciences, both into the new year and beyond.
全文を読む

In the November/December issue of PharmaVOICE, vice president of trial planning solutions Frank Cattie discusses the importance of considering protocol site work effort (SWE) in determining payment levels in order to avoid extended site negotiations, delayed start-ups and low site satisfaction.
全文を読む

Applied Clinical Trials online in November features Medidata Insights™ benchmarks for data entry times and data correction rates. Part of a monthly series highlighting industry metrics, this edition focuses on the impact of delays in entering data on the relative quality of the data being entered.
全文を読む

In InformationWeek’s 2012 State of IT Staffing Survey—which examines the evolving role of application delivery specialists and career prospects for people with these skills—senior vice president of applications and platform Vikram Shah comments on how the cloud has changed how clinical trial software is developed, deployed and delivered.
全文を読む

In this issue of Journal for Clinical Studies, director of CRO partnerships Julian de Bres shares his vision on how clinical research organizations (CROs) and their growing relationships with sponsors drive drug development and leverage clinical trial technology to optimize their studies.
全文を読む

In the fall issue of SCDM Data Basics, vice president of implementation services Marco van Doeveren discusses the power and breadth of cloud computing to better manage the increasing volume and complexity of clinical data.
全文を読む

FierceBiotechIT highlights 15 mobile apps in life sciences for 2012, including Medidata Patient Cloud™, a new app built to simplify patient data collection on iOS^® devices such as the iPhone^® and iPad^®.
全文を読む

Applied Clinical Trials online in October features a Medidata Insights™ benchmark for EDC autoquery rates. Part of a monthly series highlighting industry metrics, this edition focuses on the relationship between EDC autoquery rates and site quality.
全文を読む

In a recent Scrip Clinical Research article, director of product management Michelle Marlborough and senior manager of product marketing Joshua Pines discuss the increase in clinical trial complexity, concentrating on non-core procedures in protocol development and what organizations can do to minimize them.
全文を読む

FierceBiotech’s Ryan McBride features Medidata as a key player driving the advancement of clinical trials in Japan as vaccine maker KAKETSUKEN becomes the first Japanese pharma company to implement Medidata’s cloud-based solutions for randomization, trial supply management, electronic data capture and clinical data management.
全文を読む

In the September issue of Journal for Clinical Studies, senior manager of product marketing Sean Cheng analyzes current trends in source document verification (SDV), highlighting obstacles to overcome and pointing to the need for further awareness and adoption of risk-based practices.
全文を読む

A recent eCliniqua article highlights how Medidata’s deployment of Opscode Hosted Chef enables automated IT infrastructure in the cloud across clinical development processes, delivering new solutions securely in real-time.
全文を読む

Bio-IT World’s eCliniqua reports on the launch of new research from U.S. Department of Health and Human Services (HHS), which uses Medidata’s comprehensive trial cost database products to identify factors that delay or derail clinical studies and help assess policies that encourage and enable more streamlined and efficient trials.
全文を読む

Medidata’s vice president of information security and privacy Glenn Watt is featured in a recent Crain’s New York Business article on the popularity of hackathons as cost-effective tools to identify problems, attract talent and unleash innovation at NYC businesses. Glenn provides insight into how Medidata leverages hackathons to hack into their own code and expose bugs, helping to improve the security of its solutions for customers.
全文を読む

Applied Clinical Trials online in September features a Medidata Insights™ benchmark for query rates. Part of a monthly series highlighting industry metrics, this edition focuses on the rate at which clinical data is queried—whether by data managers, clinical (site) monitors, medical monitors or EDC systems (autoqueries)—which can be used to estimate the quality of clinical sites.
全文を読む

In a Fast Company article on key steps to building a successful business, Medidata President Glen de Vries shares about Medidata's history and growth path to becoming the forward-thinking technology company it is today.
全文を読む

Medidata's vice president of implementation services Marco van Doeveren has been named one of the most influential people in clinical technology in the PharmaVOICE 100. Marco is awarded for his efforts behind Medidata's success helping mid-market organizations to reap the full benefits of advanced technology in clinical trials.
全文を読む

In an article summarizing themes from recent tech company earnings announcements, The Street names cloud, storage and security as hot technology areas, referring to Medidata Solutions and CEO Tarek Sherif.
全文を読む

Applied Clinical Trials online in August features a Medidata Insights™ benchmark for protocol complexity. Part of a monthly series highlighting industry metrics, this edition focuses on the increasing complexity seen in clinical trials protocols in the past decade, and how despite continued warnings from experts on the topic, complexity continues on an upward, though admittedly less steep, trend.
全文を読む

In the summer issue of International Clinical Trials, director of EMEA regional sales Richard Young discusses how technology is modernizing data management best practices, helping clinical researchers to better ensure trial integrity, lower trial costs, and make a risk-based monitoring approach a reality.
全文を読む

FierceBiotech reports on the rapid growth of the eClinical market in China and other low-cost regions due to increased outsourcing and adoption of eClinical platforms like Medidata’s cloud-based solutions.
全文を読む

In a Fortune article on the impact of health care legislation on technology, executive vice president of strategy and corporate development Bryan Spielman shares how results from a recent Medidata-sponsored study—which unveiled that 25% of all clinical trial procedures are potentially unnecessary—open opportunities to increase data efficiency.
全文を読む

Outsourcing-Pharma.com spotlights Medidata’s CEO on effective M&A strategies for the clinical technology market, including targeting organizations with similar corporate cultures and complementary, rather than overlapping, capabilities.
全文を読む

In a July Outsourcing-Pharma.com article, CEO Tarek Sherif comments on the future success of the eClinical space, and how its rapid growth and change is positioning Medidata to become "the leading provider of the clinical cloud."
全文を読む

Pharmalot reports on the recent Medidata-sponsored study conducted at the Tufts Center for the Study of Drug Development, outlining key findings on unnecessary clinical trial procedures and ways to improve protocol feasibility.
全文を読む

In a July article posted on PharmaPhorum.com, senior product marketing manager Joshua Pines and senior product director Stephen Young explain how adopting site quality management can streamline monitoring and improve data quality.
全文を読む

In the summer issue of European Biopharmaceutical Review, manager of product management Sonia Araujo discusses how Europe is rewriting the rules and processes of pharmacovigilance in a move to make regulation more risk-based and proportionate, ultimately empowering patients and saving lives.
全文を読む

The Medidata-sponsored Tufts study made eCliniqua's list of top news and product releases from DIA 2012, which took place June 24–28. President Glen de Vries says the study "emphasizes the increasing role technology, and the expertise around it, will continue to play in helping drug developers design, conduct and manage efficient and effective clinical trials."
全文を読む

FierceCRO features the Medidata-sponsored study conducted by researchers from the Center for the Study of Drug Development at the Tufts University School of Medicine. The study examines data from 115 clinical trials and more than 22,000 procedures, and reveals that eliminating non-core procedures could save the industry up to $5 billion a year.
全文を読む

PharmaTimes Online highlights the Medidata-sponsored Tufts study, which showcases how clinical trial sponsors spend $3–5 billion a year in unnecessary medical procedures on patients enrolled in their clinical trials.
全文を読む

In the July issue of The New York Enterprise Report, president Glen de Vries sets the record straight about the misconceptions of owning a business in New York City, the greatest city in the world.
全文を読む

On Outsourcing-Pharma.com, director of product management Michelle Marlborough discusses new Medidata sponsored study results, which reveal up to $5 billion in potential clinical trial cost savings and how better study design can help.
全文を読む

Applied Clinical Trials online in July features Medidata Insights™ benchmarks on the increasing intensity of on-site monitoring. The annual trends of two critical monitoring efficiency metrics, Monitoring On-Site Rate and SDV Velocity, shows that site monitors are spending increasingly more days on-site per year and performing increasing amounts of SDV during each on-site day. The post is part of a monthly series highlighting industry metrics.
全文を読む

In the June issue of European Pharmaceutical Contractor, vice president of partnerships and alliances Graham Bunn discusses the evolution of engagement in CRO and sponsor relationships, and how communication and technology can shape strategic partnerships in the future.
全文を読む

In the June issue of PharmaVOICE, president Glen de Vries shares insight on the clinical cloud and how new technologies will shape the future of clinical trials.
全文を読む

President Glen de Vries discusses the political landscape of healthcare, as well as the need for more effective and more valuable therapies, in the June issue of PharmaVOICE.
全文を読む

Applied Clinical Trials online in June features a Medidata Insights™ benchmark for eCRF design complexity. Part of a monthly series highlighting industry metrics, this edition focuses on the alarming increase in complexity seen in recent years.
全文を読む

As part of a series of videos commemorating the 20th anniversary of Applied Clinical Trials, Medidata's vice president of channel sales Steve Heath discusses the past and the future of the clinical trials industry.
全文を読む

In the May issue of Pharma Focus Asia, director of China development Daniel Liu discusses the major regulatory practices related to conducting clinical trials in China, and how the quality of clinical research has improved due to the State Food and Drug Administration’s amendment of the Chinese Good Clinical Practice (GCP) guidance.
全文を読む

Westat, an employee-owned research corporation, recently introduced Medidata Rave clinical data management services to support cancer Cooperative Groups as part of the Cancer Trials Support Unit (CTSU), a program of the National Cancer Institute (NCI). Westat presented at the Americas Medidata User Group (A-MUG) in May to share its Rave-related skills and approaches.
全文を読む

The New York Times “The Boss” column features Medidata president Glen de Vries, highlighting how ballroom dancing has impacted his approach to business and helped him lead Medidata to its market-leading position today.
全文を読む

Applied Clinical Trials online in May features a Medidata Insights™ benchmark for site performance. Part of a monthly series highlighting industry metrics, this edition focuses on the high percentage of clinical trial sites that fail to enroll a single patient.
全文を読む

The Clinical Data Interchange Standards Consortium (CDISC) announces the release of the Protocol Representation "Toolkit," a standard format for study protocol data designed to save time and resources. Medidata Solutions will be providing the underlying technology for the Protocol Representation Model (PRM) Wizard, available in the next version.
全文を読む

In this April eCliniqua feature, Medidata senior business consultant Jessica Dolfi examines how technological developments can streamline site negotiation processes to accelerate site budgeting and contracting.
全文を読む

Applied Clinical Trials online in April features a Medidata Insights™ benchmark for data correction. Part of a monthly series highlighting industry metrics, this edition focuses on the remarkably low rate of post-capture data correction during clinical trials.
全文を読む

Forbes spotlights Medidata Solutions for its market leadership in software for clinical trials.
全文を読む

In its inaugural “Top 10 Biotech Techies” list, FierceBiotech honors Medidata president Glen de Vries and profiles him as builder of the clinical trial cloud.
全文を読む

FierceBiotechIT reviews Arlene Weintraub’s profile on Medidata in Xconomy and a report from TheStreet, illustrating how the company is being “lauded on Wall Street.”
全文を読む

Glenn Watt, Medidata’s vice president of information security and privacy, shares six key steps to reducing information security costs while ensuring sufficient risk controls in Information Management.
全文を読む

Applied Clinical Trials online in March features Medidata Insights™ benchmarks for form design. Part of a monthly series highlighting industry metrics, this edition highlights a surprising lack of correlation between eCRF design timelines and the rate of eCRF reuse.
全文を読む

Xconomy New York editor and veteran healthcare and life sciences writer Arlene Weintraub highlights how “Medidata Gains Raves on Wall Street,” driven by increasing demand for its cloud-based clinical development solutions and the vision and innovation of president Glen de Vries and CEO Tarek Sherif.
全文を読む

In a March ComputerWorld feature examining agile development methods and outsourcing, Medidata’s senior vice president of research and development Andrew Newbigging discusses the company’s transition to agile and why developing in-house was the better strategy for meeting customer needs.
全文を読む

Applied Clinical Trials online features a Medidata Insights™ benchmark on geographic shifts in enrollment. This unexpected trend in global subject enrollment was posted in February as part of a monthly series highlighting industry metrics.
全文を読む

FierceBiotech IT highlights Medidata as “the cloud for clinical data” in this January article featuring president Glen de Vries’ Q&A in Bio-IT World.
全文を読む

Applied Clinical Trials online features a Medidata Insights™ benchmark on source data verification, posted in January as the first of a monthly series highlighting industry metrics.
全文を読む

Medidata president Glen de Vries chats with Bio-IT World’s chief editor about the history of the company and the focus on optimizing clinical trials from concept to conclusion, in this January Q&A on the state of e-clinical technologies.
全文を読む

2011

In the fall issue of The Security Journal, Medidata's vice president of information security and privacy, Glenn Watt, discusses how organizations can view information security strategically in software development without falling victim to high costs.
全文を読む

In the December issue of Journal for Clinical Studies, Medidata authors Jessica Dolfi and Sondra Pepe discuss the impact of the impending Sunshine Act on clinical trial sponsors.
全文を読む

In eCliniqua’s December issue, Medidata’s Michelle Marlborough, director of product management, and Joshua Pines, senior product marketing manager, encourage protocol authors to think of themselves as data archaeologists, analyzing previous research to uncover and replicate best practices.
全文を読む

Medidata’s vice president of partnerships and alliances, Graham Bunn, notes the qualities of effective CRO-sponsor relationships in Life Science Leader’s December issue.
全文を読む

Medidata director of product marketing Stan Haavik, traces the development of interactive response technology (IRT) systems used in clinical trials for randomization, supply planning and implementation, in the December issue of Applied Clinical Trials.
全文を読む

In the December issue of European Pharmaceutical Review, Medidata’s senior director of development Jeffrey Cohen and senior product marketing manager Joshua Pines discuss the standards created to help simplify integration between clinical technology solutions, and the external systems managing EHRs and medical images.
全文を読む

ComputerWorld includes Medidata in a December article highlighting 10 selected firms that are looking to hire tech workers.
全文を読む

Patrick Chassaigne, director, late phase solutions, explores the patients role in Phase IV studies and registries, in the November/December Year in Preview issue of PharmaVOICE. Vice president of clinical solutions Jeffrey Handen also weighs in on engaging the patient as a drug development partner and president Glen de Vries highlights three top trends impacting R&D.
全文を読む (Patrick Chassaigne) | 全文を読む (Jeffrey Handen) | 全文を読む (Glen de Vries)

In a PharmExec guest blog post, Medidata director of late phase solutions Patrick Chassaigne discusses ways to drive patient participation in post-approval studies.
全文を読む

In the autumn 2011 issue of International Clinical Trials, Medidata’s vice president of data operations Lori Shields discusses the importance of new technological tools that help sponsors and sites meet their budget needs and increase study efficiency.
全文を読む

Medidata’s director of product management Michelle Marlborough comments on the importance of structured protocol designs to minimize costly mid-study amendments in the October 2011 issue of CenterWatch Monthly.
全文を読む

Medidata's acquisition of Clinical Force, featured in the September issue of PharmaVOICE, leads to new clinical trial management solutions (CTMS) offerings. The issue also highlights product announcements for Medidata Standards Accelerator, Insights and Coder.
全文を読む

Medidata senior vice president of development Andrew Newbigging named to PharmaVOICE 100 for his innovative efforts in clinical technology integration and commitment to advancing industry standards.
全文を読む

Medidata’s vice president of data operations Lori Shields addresses the variance in clinical trial overhead rates across sites in the July issue of The CenterWatch Monthly.
全文を読む

In a PharmaVOICE interview at the DIA Annual Meeting in Chicago, Medidata president Glen de Vries discusses ways to tackle challenges across the end-to-end clinical development process.
見る

Medidata vice president of partnerships and alliances Graham Bunn discusses the recent acquisition of Clinical Force with Outsourcing-Pharma senior editor Nick Taylor live from the DIA Annual Meeting in Chicago.
見る

Medidata director of product marketing Stan Haavik discusses the importance of process efficiency in clinical trial randomization in the June issue of PharmaVOICE.
全文を読む

Medidata executive vice president of product and marketing Lineene Krasnow comments on new approaches to address the challenges of growing protocol complexity in the June issue of PharmaVOICE.
全文を読む

Medidata vice president of product management Rick Piazza discusses the value of integration to maximize the benefits of clinical development technologies in the June issue of PharmaVOICE.
全文を読む

In the summer issue of European Pharmaceutical Contractor, Medidata senior product marketing manager Joshua Pines discusses how life science organizations can maximize the impact of EDC adoption by revisiting their internal processes and analytics tools.
全文を読む

Boston University’s Dr. Iain Cockburn discusses the use of Medidata’s trial planning data in a National Bureau of Economic Research study analyzing the increasing costs of clinical trials in this May article from ClinPage.
全文を読む

Medidata vice president of partnerships and alliances Graham Bunn discusses CRO industry trends, including the importance of strategic relationships with sponsors, in the May issue of Contract Pharma.
全文を読む

The Cancer Letter interviews Medidata president Glen de Vries about the implementation of Medidata Rave by the National Cancer Institute Cooperative Groups. Published with permission from The Cancer Letter.
全文を読む

CWWeekly's “Insider Insights” spotlights Medidata in an in-depth interview with Medidata president Glen de Vries.
全文を読む

Medidata associate product manager Keyur (Kevin) Shroff discusses six steps to streamlining the contracting of sites for clinical studies in the March issue of Journal for Clinical Studies.
全文を読む

Medidata director of late phase solutions Patrick Chassaigne weighs in on the growing importance of observational research in the March issue of R&D Directions.
全文を読む

Medidata vice president of regulatory policy Pat Beers Block and senior product director Steve Young provide commentary on the high cost and questionable impact of 100% SDV in the February issue of The CenterWatch Monthly.
全文を読む

Medidata senior director of product marketing Ron Rubinstein discusses why EDC offers an elegant solution to reducing the burden of SAE reporting for both sites and sponsors in the January/February issue of Bio-IT World.
全文を読む

2010

ビジネスコンサルタントの Jessica Dolfi が、「Scrip Clinical Research」 12月号で困難な世界経済の下で、施設予算を最適化する方法について説明
全文を読む

シニアプロダクトディレクターの Steve Young とストラテジックイニシアチブ担当ディレクターの Ashwin Mundra が、「VIEW on E-Solutions」 11/12月号でリスクベースの治験モニタリング実施における正しいツールに関して臨床組織を整備
全文を読む

メディデータの EDC エンハンスメントと会社の継続的な革新に関する「ClinPage」 10月22日のレポート
全文を読む

チャネルセールス担当バイスプレジデント、EMEA 本部長の Steve Heath が、「Journal for Clinical Studies」 9月号で浮上する国際共同研究の目的地としてオーストラリアに注力
全文を読む

シニアプロダクトディレクターの Steve Young とストラテジックイニシアチブ担当ディレクターの Ashwin Mundra が、「European Pharmaceutical Contractor」 9月号で新たな考え方としてリスクベースの治験モニタリングとパーシャル SDV について議論
全文を読む

メディデータと北京大学臨床研究所の提携が中国の創薬イノベーションおよび医薬品開発の提案を支援
全文を読む

Glen de Vries 社長が、DIA Annual Meeting の展示会場で 「PharmaVOICE」 に Software as a Service (SaaS) がスポンサー企業の R&D を最適化して、いかに臨床開発プロセスを改善するかについて説明
見る

オペレーショナルエクセレンス担当バイスプレジデントの Douglas Bain が、「eCliniqua｣ 9月21日の記事で e-sourcing の将来を洞察
全文を読む

ストラテジックイニシアチブ担当ディレクターの Ashwin Mundra が、｢Life Science Leader｣ 9月号で治験のモニタリングにおける新たな考え方について議論
全文を読む

パートナーシップ担当バイスプレジデントの Graham Bunn が、明確なビジョンを持った CRO・テクノロジーパートナーシップと業界にインスピレーションを与えるリーダーシップにより、「PharmaVOICE 100」 を受賞
全文を読む

ビジネスコンサルタント Jessica Dolfi、データ品質・解析マネージャ Rafael Campo および他業界のキスパート等が、「Applied Clinical Trials」 6月号でスタディマネージャが国際共同治験における通貨変動をいかに習得できるかについて共有
全文を読む

Drug Information Association (DIA) ミーティングで公表された無作為化および治験薬供給管理ソリューション Medidata Balance に関する 「FierceBiotech IT」 6月18日のレポート
全文を読む

Glen de Vries 社長が、ワシントンで開催されたDrug Information Association (DIA) ミーティングで2つの新製品発表について語る -6月16日「Bio-IT World」のレポート
全文を読む

メディデータとアリスグローバルによる EDC と安全性情報システムとのデータ共有に関する 「Drug Discovery & Development 」 6月16日のレポート
全文を読む

強固な臨床データ保管を提供- メディデータと SAS の提供に関する 「ClinPage」 6月15日のレポート
全文を読む

メディデータ共同創設者の Glen de Vries 社長が、「Scrip Clinical Research」 6月号で史上最も厳しい経済状況下で上場したエキサイティングな経験と今後10年間の業界ニーズに応じた会社経営について語る
全文を読む

パートナー & アライアンス担当バイスプレジデントの Graham Bunn が、「Contract Pharma」 6月号のCRO industry update で CRO がどのくらい R&D 予算絞込みの波に乗っているかについてコメントを提供
全文を読む

メディデータが ASPire to Win チャネルパートナープログラムに初めてオーストラリアの CRO を迎え入れたことに関する「Applied Clinical Trials」 6月3日のレポート
全文を読む

シニアクライアントリレーションズ担当スペシャリストの Sondra Pepe が、「Applied Clinical Trials」 6月1日の記事で国際共同試験の管理に関する洞察を提供
全文を読む

メディデータとアリスグローバルが提携し、ファーマコビジランス & 安全性情報管理システムの ARISg ソリューションと電子データ収集・管理・レポーティングソリューション Medidata Rave との統合に関する「FierceBiotech IT」 5月14日のレポート
全文を読む

クライアントサービスプリンシパルの Thomas Ermlich が、「European BioPharmaceutical Review」 春季号でいかに企業がプロセスの最適化、テクノロジーの実装と業界知識を通じて eClinical 戦略を最大化するべきかについて解説
全文を読む

シティ・オブ・ホープが EDC ソリューション10製品の評価を行った後、 Medidata Rave を選択したことに関する「FierceBiotech IT」 4月10日のレポート
全文を読む

アライアンス担当バイスプレジデントの Anne Zielinski が、「Life Science Leader」 誌 4月号で臨床試験テクノロジーに関する正しいメニューについて議論
全文を読む

インフォメーションセキュリティ & プライバシー担当バイスプレジデントの Glenn Watt が、「Bio-IT World」 1月号でクラウドコンピューティングに関するセキュリティのために臨床開発技術現場の経験を共有
全文を読む

2009

インプリメンテーションサービス担当バイスプレジデントのデイビッド ゲムズィクと業界のエキスパートが、「Drug Development」 4号で標準化で臨床研究を最適化するための CDISC protocol representation model について議論
全文を読む

ロシュが「ACDM newsletter」Data Matters の秋季号で如何にロシュの新しいEDCシステム、Medidata Rave を上手く導入、管理しているかを解説 全文を読む インプリメンテーションサービス担当バイスプレジデントのデイビッド ゲムズィクが、「European Pharmaceutical Contractor」 12月号で理にかなった臨床試験のために、高品質のプロトコール開発プログラムによる tips を提供
全文を読む

アライアンス担当バイスプレジデントのアン ジリンスキーが、「Contract Pharma」 11/12月号で開発業務受託機関 (CROs) と電子データ収集 (EDC) が理想的に適合するか、それとも不安な連携であるかを解説
全文を読む

インプリメンテーションサービス担当バイスプレジデントのデイビッド ゲムズィクとシニア プロダクトマーケティング マネージャのショーン チェンが、「VIEW on E-Solutions」 11月号でスポンサーがクローズドループの臨床プロセスを必要とする理由を説明
全文を読む

バイスプレジデント、EMEAビジネス本部長のスティーブ ヒースと品質保証担当シニア ディレクターのトニー ヒューワーが、「Life Science Leader」 11月号でテクノロジーは、社会・規制機関とライフサイエンス業界との間でどう支援されるかを議論
全文を読む

バイスプレジデント、EMEAビジネス本部長のスティーブ ヒースが、「Journal for Clinical Studies」 秋季号で中小規模のバイオテクノロジーおよび製薬企業が、今日の経済状況下でどのようにeClinical戦略を築き上げることができるかについて解説
全文を読む

EMEA ビジネス本部長のスティーブ ヒースが、「Journal for Clinical Studies」 7月号でエディトリアル アドバイザリ キーノートを提供
全文を読む

グレン デフリース社長とSAS社ヘルス/ライフサイエンス市場セグメントのグローバルディレクター、ジェイソン パーク氏が、Bio-IT Worldのポッドキャストで臨床試験と医薬品開発のためのソリューション提供について議論
全文を読む

インプリメンテーション・サービス担当バイスプレジデントのムクター アーメドが、「European Pharmaceutical Contractor」 でアジア太平洋地域の成長とチャレンジを見る